{"id":9120,"date":"2025-11-19T18:56:32","date_gmt":"2025-11-19T18:56:32","guid":{"rendered":"https:\/\/traumanet.nl\/?post_type=artikelen&p=9120"},"modified":"2026-02-26T07:40:56","modified_gmt":"2026-02-26T07:40:56","slug":"why-mdma-for-ptsd","status":"publish","type":"artikelen","link":"https:\/\/traumanet.nl\/en\/artikelen\/waarom-mdma-bij-ptss\/","title":{"rendered":"Why MDMA for PTSD?"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u201cI see a way forward again,<\/em>\u201d said a participant during his first MDMA session. He had been suffering from severe for years PTSD<\/a> due to war traumas that haunted him daily. After countless treatments, he had virtually given up hope of recovery.<\/p>

Under the influence of the experimental MDMA, and with the support of his therapists, something shifted. For the first time, he was able to speak about what he had been unable to face for years, without the usual tension, shame, and self-reproach. At rest, completely attuned with his therapists, he dared to feel what had previously been unbearable. Even after the study ended, that process continued. After years of feeling stuck, there was finally a breakthrough, and once again a glimpse of his future.<\/p>

With PTSD, fear, shame, and physical tension often remain active, as if the danger is still directly present. Many people try to avoid those feelings or become disconnected from their emotions and body. These are survival reactions<\/a> that once helped to stay afloat, but can also stand in the way of recovery. In therapy, we try to recall those memories and feelings in a controlled manner so that they can be processed. But that is not easy. Therapy can stall for various reasons: sometimes the fear is too great, sometimes trust is lacking, or someone feels so disconnected from themselves that little can be reached.<\/p>

Precisely there, MDMA can add something, not by taking over the work, but by temporarily creating more space. It reduces anxiety, strengthens connection, and enables self-compassion. Thus, what previously remained unreachable can be cautiously approached.<\/p>

At first glance it seems strange: a substance known as ecstasy, now being investigated as a potential treatment for PTSD. Yet that is less crazy than it sounds. MDMA has been thoroughly researched for decades. We know that it releases various substances in the brain, improving mood, energy, and mental clarity. Fear diminishes, while feelings of connectedness and self-compassion<\/a> just increasing.<\/p>

The condition lasts for several hours and creates precisely what is essential in therapy: safety, openness, and emotional closeness. In this way, MDMA acts like a kind of Swiss Army knife, able to tackle multiple blocks at the same time that stand in the way of therapy. If you had to imagine what a substance would look like that could help break through treatment-resistant PTSD, it would probably look a lot like MDMA.<\/p>

MDMA can deepen therapy, but that does not mean it is easy. The substance helps make difficult feelings temporarily more tolerable, without numbing them. Fear and pain remain palpable, but become less overwhelming. For many people with severe PTSD, the very idea of taking something that causes them to temporarily relinquish some control and experience intense feelings for hours is daunting\u2014often precisely what they normally avoid. Of course, we also see side effects, but those are rarely a problem during the therapy being studied. That is quite different when you take XTC at a party where the dose and environment are often unpredictable and there is no guidance.<\/p>

Many patients experience the sessions as intense. That is why we prepare everything carefully with well-trained therapists, and guidance is also provided after the session. MDMA is not a cure-all. Even though research shows that MDMA-assisted therapy helps many people with PTSD, it does not work for everyone. The substance opens doors, but the healing takes place within the therapeutic process, in feeling, understanding, and processing the trauma. Next time, I will go into more detail about what exactly happens during the therapeutic trajectory, and why that forms the true heart of the treatment.<\/p>

\u00a0<\/p>

For more information about MDMA-assisted therapy, visit arq.org<\/a><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Tijmen\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Tijmen Bostoen<\/h4>

Psychiatrist and researcher at ARQ National Psychotrauma Centre and the Leiden University Medical Center.<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t
More about Tijmen <\/div><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/path><\/svg><\/span>\n\t\t\t<\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Tijmen specializes in trauma-related disorders and in the development of psychedelic-assisted psychotherapy. He is trained in MDMA- and ketamine-assisted therapy and is involved in multiple (international) studies. In addition, he develops training programs for therapists, with a focus on experiential work, altered states of consciousness, and psychedelics.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

\u201cIk zie weer een weg vooruit,\u201d zei een deelnemer tijdens zijn eerste MDMA-sessie. Hij leed al jaren aan ernstige PTSS door oorlogstrauma\u2019s die hem dagelijks achtervolgden. Na talloze behandelingen had hij de hoop op herstel vrijwel opgegeven. Onder invloed van het experimentele MDMA, en met de steun van zijn therapeuten, kwam er iets in beweging. […]<\/p>\n","protected":false},"author":162,"featured_media":9122,"parent":0,"template":"","meta":{"_acf_changed":false,"give_campaign_id":0},"artikel-categorie":[60],"doelgroep":[12,13],"thema":[50],"trefwoord":[],"class_list":["post-9120","artikelen","type-artikelen","status-publish","has-post-thumbnail","hentry","artikel-categorie-column","doelgroep-iemand-met-trauma","doelgroep-iemand-in-mijn-omgeving-heeft-trauma","thema-hulp-en-steun-bij-trauma"],"acf":[],"yoast_head":"\nWaarom MDMA bij PTSS? | Column Tijmen Bostoen<\/title>\n<meta name=\"description\" content=\"Tijmen is psychiater en onderzoeker bij ARQ Centrum \u201945. Hij is gespecialiseerd in de ontwikkeling van psychedelica-ondersteunde psychotherapie.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/traumanet.nl\/en\/articles\/why-mdma-for-ptsd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Waarom MDMA bij PTSS?\" \/>\n<meta property=\"og:description\" content=\"Tijmen is psychiater en onderzoeker bij ARQ Centrum \u201945. Hij is gespecialiseerd in de ontwikkeling van psychedelica-ondersteunde psychotherapie.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/traumanet.nl\/en\/articles\/why-mdma-for-ptsd\/\" \/>\n<meta property=\"og:site_name\" content=\"Traumanet\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/traumanetnl\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-26T07:40:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/traumanet.nl\/wp-content\/uploads\/2025\/11\/Tijmen-Bostoen.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"550\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/\",\"url\":\"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/\",\"name\":\"Waarom MDMA bij PTSS? | Column Tijmen Bostoen\",\"isPartOf\":{\"@id\":\"https:\/\/traumanet.nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/traumanet.nl\/wp-content\/uploads\/2025\/11\/Tijmen-Bostoen.jpg\",\"datePublished\":\"2025-11-19T18:56:32+00:00\",\"dateModified\":\"2026-02-26T07:40:56+00:00\",\"description\":\"Tijmen is psychiater en onderzoeker bij ARQ Centrum \u201945. Hij is gespecialiseerd in de ontwikkeling van psychedelica-ondersteunde psychotherapie.\",\"breadcrumb\":{\"@id\":\"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#primaryimage\",\"url\":\"https:\/\/traumanet.nl\/wp-content\/uploads\/2025\/11\/Tijmen-Bostoen.jpg\",\"contentUrl\":\"https:\/\/traumanet.nl\/wp-content\/uploads\/2025\/11\/Tijmen-Bostoen.jpg\",\"width\":550,\"height\":350,\"caption\":\"Tijmen Bostoen\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/traumanet.nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artikelen\",\"item\":\"https:\/\/traumanet.nl\/artikelen\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Waarom MDMA bij PTSS?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/traumanet.nl\/#website\",\"url\":\"https:\/\/traumanet.nl\/\",\"name\":\"Traumanet\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/traumanet.nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/traumanet.nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/traumanet.nl\/#organization\",\"name\":\"Stichting Traumanet\",\"url\":\"https:\/\/traumanet.nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/traumanet.nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/traumanet.nl\/wp-content\/uploads\/2024\/09\/logo.svg\",\"contentUrl\":\"https:\/\/traumanet.nl\/wp-content\/uploads\/2024\/09\/logo.svg\",\"width\":195,\"height\":37,\"caption\":\"Stichting Traumanet\"},\"image\":{\"@id\":\"https:\/\/traumanet.nl\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/traumanetnl\",\"https:\/\/www.linkedin.com\/company\/traumanet\/\",\"https:\/\/www.instagram.com\/traumanet\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Why MDMA for PTSD? | Column Tijmen Bostoen","description":"Tijmen is a psychiatrist and researcher at ARQ National Psychotrauma Centre. He specializes in the development of psychedelic-assisted psychotherapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/traumanet.nl\/en\/articles\/why-mdma-for-ptsd\/","og_locale":"en_US","og_type":"article","og_title":"Waarom MDMA bij PTSS?","og_description":"Tijmen is psychiater en onderzoeker bij ARQ Centrum \u201945. Hij is gespecialiseerd in de ontwikkeling van psychedelica-ondersteunde psychotherapie.","og_url":"https:\/\/traumanet.nl\/en\/articles\/why-mdma-for-ptsd\/","og_site_name":"Traumanet","article_publisher":"https:\/\/www.facebook.com\/traumanetnl","article_modified_time":"2026-02-26T07:40:56+00:00","og_image":[{"width":550,"height":350,"url":"https:\/\/traumanet.nl\/wp-content\/uploads\/2025\/11\/Tijmen-Bostoen.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/","url":"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/","name":"Why MDMA for PTSD? | Column Tijmen Bostoen","isPartOf":{"@id":"https:\/\/traumanet.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#primaryimage"},"image":{"@id":"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#primaryimage"},"thumbnailUrl":"https:\/\/traumanet.nl\/wp-content\/uploads\/2025\/11\/Tijmen-Bostoen.jpg","datePublished":"2025-11-19T18:56:32+00:00","dateModified":"2026-02-26T07:40:56+00:00","description":"Tijmen is a psychiatrist and researcher at ARQ National Psychotrauma Centre. He specializes in the development of psychedelic-assisted psychotherapy.","breadcrumb":{"@id":"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#primaryimage","url":"https:\/\/traumanet.nl\/wp-content\/uploads\/2025\/11\/Tijmen-Bostoen.jpg","contentUrl":"https:\/\/traumanet.nl\/wp-content\/uploads\/2025\/11\/Tijmen-Bostoen.jpg","width":550,"height":350,"caption":"Tijmen Bostoen"},{"@type":"BreadcrumbList","@id":"https:\/\/traumanet.nl\/artikelen\/waarom-mdma-bij-ptss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/traumanet.nl\/"},{"@type":"ListItem","position":2,"name":"Artikelen","item":"https:\/\/traumanet.nl\/artikelen\/"},{"@type":"ListItem","position":3,"name":"Waarom MDMA bij PTSS?"}]},{"@type":"WebSite","@id":"https:\/\/traumanet.nl\/#website","url":"https:\/\/traumanet.nl\/","name":"Traumanet","description":"","publisher":{"@id":"https:\/\/traumanet.nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/traumanet.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/traumanet.nl\/#organization","name":"Traumanet Foundation","url":"https:\/\/traumanet.nl\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/traumanet.nl\/#\/schema\/logo\/image\/","url":"https:\/\/traumanet.nl\/wp-content\/uploads\/2024\/09\/logo.svg","contentUrl":"https:\/\/traumanet.nl\/wp-content\/uploads\/2024\/09\/logo.svg","width":195,"height":37,"caption":"Stichting Traumanet"},"image":{"@id":"https:\/\/traumanet.nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/traumanetnl","https:\/\/www.linkedin.com\/company\/traumanet\/","https:\/\/www.instagram.com\/traumanet\/"]}]}},"_links":{"self":[{"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/artikelen\/9120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/artikelen"}],"about":[{"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/types\/artikelen"}],"author":[{"embeddable":true,"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/users\/162"}],"version-history":[{"count":8,"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/artikelen\/9120\/revisions"}],"predecessor-version":[{"id":9149,"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/artikelen\/9120\/revisions\/9149"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/media\/9122"}],"wp:attachment":[{"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/media?parent=9120"}],"wp:term":[{"taxonomy":"artikel-categorie","embeddable":true,"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/artikel-categorie?post=9120"},{"taxonomy":"doelgroep","embeddable":true,"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/doelgroep?post=9120"},{"taxonomy":"thema","embeddable":true,"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/thema?post=9120"},{"taxonomy":"trefwoord","embeddable":true,"href":"https:\/\/traumanet.nl\/en\/wp-json\/wp\/v2\/trefwoord?post=9120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}